(Q44394321)

2 December 2017

title

Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study (English)

1 reference

2 December 2017

0 references

2

1 reference

2 December 2017

Caputo F

1

1 reference

2 December 2017

Lorenzini F

3

1 reference

2 December 2017

Domenicali M

4

1 reference

2 December 2017

Greco G

5

1 reference

2 December 2017

del RE A

6

1 reference

2 December 2017

Gasbarrini G

7

1 reference

2 December 2017

Stefanini GF

8

1 reference

2 December 2017

Bernardi M

9

1 reference

2 December 2017

publication date

1 May 2003

1 reference

Drug and Alcohol Dependence

2 December 2017

published in

1 reference

2 December 2017

volume

70

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

85-91

1 reference

An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Gamma-hydroxybutyric acid efficacy, potential abuse, and dependence in the treatment of alcohol addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Gamma-hydroxybutyric acid reducing effect on ethanol intake: evidence in favour of a substitution mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Involvement of GABA(A) and GABA(B) receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Outcome variables in the evaluation of alcoholics' treatment: lessons from the Italian Assessment of Alcoholism Treatment (ASSALT) Project

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Naltrexone-induced dysphoria in former opioid addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Naloxone antagonizes ethanol- but not gamma-hydroxybutyrate-induced sleep in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Mechanism of the antialcohol effect of gamma-hydroxybutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Effect of Fluoxetine on Alcohol Consumption in Male Alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Alcohol reinforcement and neuropharmacological therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Long-term therapy using GHB (sodium gamma hydroxybutyrate) for treatment-resistant chronic alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

GHB: a new and novel drug of abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Pharmacologic treatment of heroin-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Patients with alcohol problems

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Gamma hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Gamma-hydroxybutyrate, a possible neurotransmitter.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Comparison of acamprosate and placebo in long-term treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

Adverse events, including death, associated with the use of 1,4-butanediol

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900340-X

7 January 2021

10.1016/S0376-8716(02)00340-X

Identifiers

DOI

1 reference

2 December 2017

1 reference